VDR and colonic neoplasm: For example, in colon cancer, it has been seen that vitamin D has demonstrated therapeutic potential but may be limited due to VDR mutations [50], and a combinatorial approach of a rexinoid and a VDR ligand could help mitigate any effects of VDR mutations.